Rise Consulting Group, Inc. Logo

Rise Consulting Group, Inc.

Execution-focused consulting for strategy and digital transformation, specializing in JP-CN markets.

9168 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
港区六本木1−6−1 泉ガーデンタワー34階
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Rise Consulting Group, Inc. is a comprehensive consulting firm that specializes in providing execution-focused support to drive client growth. The company offers a wide range of services, including corporate strategy formulation, digital transformation, IT and new technology consulting, M -A advisory, overseas expansion support, and business process re-engineering (BPR). Distinguishing itself from traditional consultancies, Rise Consulting Group emphasizes hands-on implementation and the delivery of tangible results over theoretical reports. The firm provides end-to-end support, from initial concept and proof of concept (PoC) to full execution, with a notable focus on facilitating business between Japanese and Chinese markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-30 07:32
Regulatory News Service
臨時報告書
Japanese 25.6 KB
2025-05-30 02:32
Registration Form
確認書
Japanese 8.9 KB
2025-05-30 02:28
Registration Form
訂正有価証券報告書-第5期(2024/03/01-2025/02/28)
Japanese 1.5 MB
2025-05-29 08:44
Governance Information
内部統制報告書-第5期(2024/03/01-2025/02/28)
Japanese 23.4 KB
2025-05-29 08:38
Registration Form
確認書
Japanese 8.8 KB
2025-05-29 08:30
Registration Form
有価証券報告書-第5期(2024/03/01-2025/02/28)
Japanese 2.8 MB
2025-04-24 08:50
Major Shareholding Notification
臨時報告書
Japanese 21.2 KB
2025-04-07 09:01
Board/Management Information
臨時報告書
Japanese 22.0 KB
2024-10-15 08:07
Report Publication Announcement
確認書
Japanese 8.9 KB
2024-10-15 08:04
Interim Report
半期報告書-第5期(2024/03/01-2025/02/28)
Japanese 242.2 KB
2024-08-15 09:45
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.8 KB
2024-07-12 08:12
Regulatory News Service
確認書
Japanese 8.8 KB
2024-07-12 08:10
Quarterly Report
四半期報告書-第5期第1四半期(2024/03/01-2024/05/31)
Japanese 200.3 KB
2024-06-10 06:00
Major Shareholding Notification
臨時報告書
Japanese 20.5 KB
2024-06-04 07:56
Post-Annual General Meeting Information
臨時報告書
Japanese 27.0 KB

Automate Your Workflow. Get a real-time feed of all Rise Consulting Group, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Rise Consulting Group, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
DT&CRO CO., Ltd. Logo
A full-service CRO for pharma & biotech, from non-clinical studies to FDA approval support.
South Korea 383930
DUSKIN CO.,LTD. Logo
Franchises cleaning rentals and services for homes and businesses, and operates food chains.
Japan 4665
D.Western Therapeutics Institute, Inc. Logo
Biotech firm discovering and licensing drug candidates, focusing on kinase inhibitors.
Japan 4576
ECHOMARKETING Co.,Ltd. Logo
Global agency accelerating sales with data-driven, full-funnel digital marketing.
South Korea 230360
Eezy Oyj Logo
HR services firm for the full employment lifecycle, from recruitment to freelancer support.
Finland EEZY
Enjin Co., Ltd. Logo
PR firm for SMEs and medical institutions, offering consulting and a media matching platform.
Japan 7370
Ensol Biosciences Inc. Logo
Develops AI-discovered peptide drugs for cancer, osteoarthritis, and Alzheimer's disease.
South Korea 140610
Eutilex Co.,Ltd. Logo
Develops T-cell and antibody immunotherapies for cancer and autoimmune diseases.
South Korea 263050
Evogene Ltd. Logo
AI-powered platform designing life-science solutions for health, ag, and industrial sectors.
Israel EVGN
EXACT Therapeutics AS Logo
Biopharma firm using ultrasound to enhance drug delivery for oncology via its ACT® platform.
Norway EXTX

Talk to a Data Expert

Have a question? We'll get back to you promptly.